Ira Duarte Net Worth & Insider Trades
Ira Duarte - EVP, Heron Therapeutics, Inc
What is Ira Duarte's Net Worth?
The current estimated net worth of Heron Therapeutics, Inc's EVP, Ira Duarte, is estimated to be about $311.2K . Ira Duarte owns about 85,000 units of Heron Therapeutics, Inc common stock. Recently at Heron Therapeutics, Inc, Ira Duarte has sold an estimated value of $0 worth.
What is Ira Duarte's Past Insider Trading?
Ira Duarte's largest purchase order was 85,000 units , worth over $75.6K on November 17, 2023. In total, Ira Duarte has made about 1 transaction recently at Heron Therapeutics, Inc. Ira Duarte usually trades in November, with the busiest year in 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ira Duarte
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Ira Duarte's' Mailing Address?
- Mailing address is 1255 Crescent Green Drive Suite 250 Cary NC 27518 NC
Heron Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|
Barry Quart, Pharm.D. | 2020 | $676,838 | $916,995 | $364,991 | $364,991 | $21,084 | $5,346,803 |
Barry Quart, Pharm.D. | 2019 | $638,991 | - | $306,715 | $306,715 | $8,400 | $5,870,479 |
Barry Quart, Pharm.D. | 2018 | $614,414 | - | $552,973 | $552,973 | $8,250 | $5,991,297 |
John Poyhonen | 2020 | $513,935 | $314,400 | $197,960 | $197,960 | $8,550 | $2,670,194 |
John Poyhonen | 2019 | $216,731 | - | $90,751 | $90,751 | $6,219 | $4,524,764 |
Kimberly Manhard | 2020 | $519,167 | $314,400 | $199,976 | $199,976 | $8,550 | $2,196,457 |
Kimberly Manhard | 2019 | $490,136 | - | $196,054 | $196,054 | $8,400 | $2,509,866 |
Kimberly Manhard | 2018 | $466,796 | - | $350,097 | $350,097 | $8,250 | $2,430,363 |
David Szekeres | 2020 | $476,910 | $314,400 | $161,664 | $161,664 | $8,550 | $2,462,197 |
Lisa Peraza | 2020 | $328,805 | $138,855 | $105,683 | $105,683 | $14,567 | $1,578,739 |
Robert Hoffman | 2020 | $360,009 | - | - | - | $668,287 | $1,028,296 |
Robert Hoffman | 2019 | $388,714 | - | $124,388 | $124,388 | $8,400 | $2,034,232 |
Robert Hoffman | 2018 | $357,438 | - | $214,463 | $214,463 | $8,027 | $1,719,634 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/818033/000156459021020104/hrtx-def14a_20210617.htm
What are Heron Therapeutics, Inc's Past Insider Trades?
Heron Therapeutics, Inc's most recent insider trade came on November 21, 2023 by William Forbes who bought 25,000 units worth $27.25K . In the last 9 years, insiders at Heron Therapeutics, Inc have sold an estimated value of $130.42M and bought an estimated value of $70.53M worth of shares. Insider trading is most common in December, with the busiest year in 2021. The most active traders at the company are Kimberly Manhard, EVP, Barry D Quart, Chief Executive Officer, and John Poyhonen, President & CCO .
HERON THERAPEUTICS, INC. /DE/ Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |